Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Policy & Regulation
Trends & Finance
Trends and Finance: Page 3
Magritek enhances benchtop NMR instruments
By
LabPulse.com staff writers
Nuclear magnetic resonance software builds capabilities for labs looking for synthetic drugs and new psychoactive substances, using benchtop NMR instruments.
March 29, 2024
Florida man pleads guilty in $4.6 million kickback scheme
By
LabPulse.com staff writers
A Tampa, FL man pleaded guilty for his role in a scheme to receive kickbacks and bribes from labs in exchange for referrals of patient DNA samples and genetic tests, according to the U.S. Attorney's Office for the District of New Jersey.
March 29, 2024
Labcorp acquires BioReference Health assets
By
LabPulse.com staff writers
Labcorp and Opko Health subsidiary BioReference Health have announced that they have made an agreement for Labcorp to acquire certain of BioReference Health’s assets.
March 28, 2024
AbbVie to buy Landos Biopharma for up to $212M
By
LabPulse.com staff writers
AbbVie has announced that it will buy drug developer Landos Biopharma in a deal worth up to $212 million. The deal will expand Abbvie’s portfolio, especially in the arena of immune system-related illnesses.
March 25, 2024
Protein design firm Profluent raises $35M in funding
By
LabPulse.com staff writers
Protein design firm Profluent has raised $35 million in funding, bringing the total funding raised by the company to $44 million.
March 25, 2024
Bluebird Bio secures up to $175M in debt financing
By
LabPulse.com staff writers
Bluebird Bio has secured up to $175 million in debt financing with Hercules Capital, having entered into a five-year term loan facility that provides funds in separate tranches.
March 18, 2024
Siemens Healthineers to close Fast Track Diagnostics unit
By
LabPulse.com staff writers
Siemens Healthineers intends to close its Fast Track Diagnostics unit by September 2024.
March 19, 2024
Oxford Nanopore, SeqOne to collaborate on sequencing platform
By
LabPulse.com staff writers
Oxford Nanopore and genomics firm SeqOne are collaborating on an end-to-end platform for whole-genome nanopore sequencing reads for clinical diagnostic testing.
March 18, 2024
NGeneBio, Genolution to collaborate on automated NGS system
By
LabPulse.com staff writers
Precision diagnostics company NGeneBio and molecular diagnostics firm Genolution have signed a memorandum of understanding to develop and launch an automated next-generation sequencing (NGS) system.
March 14, 2024
Zephyr AI closes $111M series A funding round
By
LabPulse.com staff writers
Biotech startup Zephyr AI announced on Wednesday that it successfully closed a $111 million series A funding round.
March 13, 2024
T2 Biosystems granted Nasdaq listing extension
By
LabPulse.com staff writers
Nasdaq's Hearings Panel has granted T2 Biosystems' request for an extension for continued listing on the stock market subject to T2 complying with Nasdaq's rule for market value of listed securities.
March 12, 2024
Patient Square Capital to acquire NanoString assets for $220M
By
LabPulse.com staff writers
NanoString Technologies has reached a binding agreement with Patient Square Capital in which NanoString will sell substantially all of its assets to the investment firm for $220 million.
March 11, 2024
Previous Page
Page 3 of 133
Next Page